drugset / Trial / NCT06936943
ONO-4538 Study in Patients With Richter's Transformation
NaSingle-groupOpen-labelTreatment
Summary
Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation
Timeline
- Start
- 2025-11-19
- Primary completion
- 2029-07-31
- Completion
- 2030-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nivolumab | Monoclonal antibody | 480 mg | Intravenous |